NCT05683912View on ClinicalTrials.gov

Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

September 1, 2021

Study Completion Date

December 15, 2022

Conditions
Diabetic Macular Edema
Interventions
DRUG

Aflibercept

Intravitreal aflibercept as used in the routice clinical practice

Trial Locations (1)

12462

University of Athens, Athens

All Listed Sponsors
lead

University of Athens

OTHER

NCT05683912 - Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece | Biotech Hunter | Biotech Hunter